Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Low Dose
Total, all-cause mortality	Mid Dose
Total, all-cause mortality	High Dose
Total, all-cause mortality	Single High Dose
Total, all-cause mortality	Placebo
Total, other adverse events	Low Dose	17	83
Total, other adverse events	Mid Dose	18	88
Total, other adverse events	High Dose	21	83
Total, other adverse events	Single High Dose	15	83
Total, other adverse events	Placebo	16	84
Total, serious adverse events	Low Dose	1	83
Total, serious adverse events	Mid Dose	2	88
Total, serious adverse events	High Dose	3	83
Total, serious adverse events	Single High Dose	3	83
Total, serious adverse events	Placebo	2	84

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01091116/event-totals